| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Laboratory of Cell Biology [M-J. P., I-C. P., C. H. R., H-S. K., S-I. H., S-H. L], Korea Cancer Center Hospital, Seoul 139-706, Korea, and Neurooncology Clinic [M-S. K., H. Y., S-H. L.], Division of Basic Science [S. H. P.], National Cancer Center, Goyang, Gyeonggi, 411-351, Korea
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
HA is the principal glycosaminoglycan found in extracellular matrix of brain. It binds to cell-surface receptors such as CD44 and appears to be involved in cell adhesion, migration, proliferation, and tumor progression (4 , 5) . In human brain, HA is distributed in white matter fiber tracts, which form the most frequent route of glioma dissemination (6) . There are several studies that suggest an important role of HA in glioma cell invasion in vitro (7 , 8) . However, there have been only few studies on the molecular mechanism of HA-mediated invasion of glioma cells (9) . Furthermore, the specific role of HA on the secretion of MMPs and the invasion by glioma cells is not well understood.
PTEN (also called MMAC1) is a tumor-suppressor gene located on human chromosome 10q23.3 (10 , 11) , and it regulates cell growth, apoptosis (12) , and interaction with the extracellular matrix, and inhibits cell migration, spreading, and focal adhesion (13) . PTEN protein exhibits dual specificity protein phosphatase activity in vitro (14) and its potential cellular target of FAK (15) . However, it can also dephosphorylate the lipid signal transduction molecules phosphatidylinositol 3,4,5-triphosphate and phosphatidylinositol 3,4-bisphosphate, which are both involved in the PI3K pathway (14) . It has been suggested that dephosphorylation of FAK by the PTEN protein is correlated with cell spreading, migration, and invasion (13 , 15) . In addition, Koul et al. (16) recently reported that PTEN suppresses MMP-2 gene expression, and invasion of glioma cells and phosphatase activity is essential in these events. On the other hand, it has also been reported that the lipid phosphatase activity of PTEN is not required in the invasive potential of glioma cells (17) .
In this report, we describe the effect of HA on the secretion of MMP-9 and invasion of human glioma cell lines, and the role of PTEN in these events. Our findings suggest that PTEN suppresses HA-induced secretion of MMP-9, possibly through FAK dephosphorylation; thus, PTEN inhibits HA-induced invasion via control of MMP-9 secretion.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Plasmid Construction and Cell Transfection.
wt-PTEN cDNA was obtained from Dr. Hong Sun (Yale University, New Haven, CT) and cloned into pcDNA3 vector to generate pcDNA3-PTEN. The entire open reading frame was sequenced to confirm the correct sequence. U87MG cells were transfected with pcDNA3-PTEN or pcDNA3 (no insert) in triplicate dishes and in three independent experiments by using the Effectene reagent (Qiagen, Valencia, CA) according to the manufacturers protocol. After 24 h, cells were split at a 1:5 dilution and exposed for 23 weeks in G418 (Boehringer Mannheim, Indianapolis, IN)-containing medium (800 µg/ml) and colonies were picked for their resistance to G418. Expression of PTEN was confirmed by Western blot analysis using a monoclonal antibody against PTEN.
Construction and Infection of Recombinant Adenovirus.
To construct Ad-PTEN vectors, 1.2-kb fragments of PTEN cDNAs [wt- and mutant type-PTEN (C124S and G129E, a generous gift from Dr. Young E. Whang, University of North Carolina School of Medicine, Chapel Hill, NC)] were cloned into the KpnI and XhoI sites of pShuttle-CMV vector (AdEasy Adenoviral Vector System; Stratagene, La Jolla, CA) and cotransformed into Escherichia coli BJ5183 cells with the pAdEasy-1 vector, using the electroporation method and selected colonies harboring homologous recombinant plasmid in agar plates containing kanamycin, as described in the manufacturers protocol. Recombinant adenoviruses were produced by transfection of homologous recombinant plasmid into the HEK cell line 293. As a control, Ad-LacZ was made from pSuttle-CMV-lacZ encoding the ß-gal gene in the manner described previously. Viruses were propagated in the HEK293 cell line and purified by two rounds of CsCl density centrifugation; viral titers were measured in a limiting-dilution bioassay using the HEK293 cells. The recombinant adenoviruses were infected into glioma cells with 50 plaque-forming units per cell in serum-free medium containing 2.5 mg of Polybrene (Sigma) per ml and incubated for 90 min at 37°C.
Transfection of Antisense Oligonucleotides of FAK.
FAK sense (5'-AGTTCCATTCGTCGACGGTA-3') and antisense (5'-AAGCAGCTGCCATTATTTTG-3') phosphorothioate oligonucleotides were obtained from Bioneer Co. (Cheongwon, Chungbuk, Korea) and each olignucleotide was transfected into U87MG cells using Effectene reagent following the suppliers instructions.
Gelatin Zymography.
Glioma cells in subconfluent culture (
7080% cell density of confluent culture) were washed and refreshed with serum-free DMEM and were incubated with or without HA for 18 h. In some experiments, cells were preincubated for 30 min with various kinase inhibitors before the addition of HA. The enzymatic activity and molecular weight of electrophoretically separated gelatinolytic enzymes in the conditioned medium of glioma cells were determined by SDS-PAGE as follows. Twenty µl of serum-free culture medium per sample were prepared in nondenaturing loading buffer (0.5 M Tris-HCl, pH 6.8, 10% SDS, 0.1% bromophenol blue, and 10% glycerol) and were size-fractionated in 10% SDS-polyacrylamide gel impregnated with 0.1% gelatin. The gels were then washed with 2.5% Triton X-100 for 1 h at room temperature to remove SDS, rinsed twice with water, and then incubated in a developing buffer [50 mM Tris-HCl buffer (pH 7.4), 20 mM NaCl, 10 mM CaCl2, and 0.1 NaN3] for 18 h at 37°C. Subsequently, gels were fixed and stained with 10% 2-propanol and 10% acetic acid containing 0.5% Coomassie Blue R250. Gelatinase activity was visualized as clear bands within the stained gel.
Western Blot Analysis.
The activation of ERK 1/2 and FAK was determined by Western blotting using antibodies specific for phosphorylated forms of the corresponding to ERK 1/2 and FAK. Glioma cells were stimulated with HA at 100 µg/ml and lysed in lysis buffer [20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium PPI, 1 mM ß-glycerolphosphate, 1 mM Na3VO4, 1 µg/ml leupeptin, and 1 mM phenolmethylsulfonyl fluoride]. After a brief sonication, the lysates were clarified by centrifugation at 12,000 x g for 15 min at 4°C, and protein content was measured by a Bradfords method. An aliquot (30 µg protein/lane) of the total protein was separated by 10 or 12% SDS-PAGE and blotted to nitrocellulose transfer membrane (0.2 µm; Amersham, Arlington Heights, IL). The membrane was blocked with 5% nonfat skim milk in TBST [20 mM Tris-HCl (pH 7.6), 137 mM NaCl, and 0.01% Tween 20] for 1 h at room temperature, followed by incubation with the primary antibodies. After extensive washing with TBST, the membrane was reprobed with the secondary antibody of horseradish peroxidase-linked antirabbit immunoglobulin at 1:3,000 in TBST for 40 min at room temperature. Immunoblots were visualized by enhanced chemiluminescence (Amersham), according to the manufacturers protocol.
Conditioned medium from each sample was also subjected to protein analysis of MMP-2 and -9 and TIMP-1 and -2. For this purpose, culture medium in each tissue culture dish was collected and concentrated using a Centricon 10 microconcentrator (Amicon, Beverly, MA), and 5-fold concentrated conditioned medium (20 µl) was then used for SDS-PAGE analysis.
In Vitro Invasion Assay.
Invasion assays were performed using modified Boyden chambers with polycarbonate Nucleopore membrane (Corning, Corning, NY). Precoated filters (6.5 mm in diameter, 8 µm pore-size, Matrigel 100 µg/cm2) were rehydrated with 100 µl of medium, and 2 x 105 cells in 100 µl of medium, with or without HA, were seeded in triplicate into the upper part of each chamber, and the lower compartment was filled with 1 ml of serum-free DMEM supplemented with 0.1% BSA. After incubation for 18 h at 37°C, noninvaded cells on the upper surface of the filter were wiped with a cotton swab, and migrated cells on the lower surface of the filter were fixed and stained with Diff-Quick kit. Invasiveness was determined by counting cells in five microscopic fields per well, and the extent of invasion was expressed as an average number of cells per microscopic field.
| RESULTS |
|---|
|
|
|---|
|
|
Ras, FAK, and ERK 1/2 Signaling Plays a Role in HA-induced MMP-9 Secretion in U87MG Cells and PTEN Inhibits These Signaling Pathways.
Because PTEN is a dual specificity phosphatase, we next examined the involvement of phosphorylation of various kinases in HA-induced MMP-9 secretion using specific kinase inhibitors. Gelatin zymogram analysis showed that the secretion of HA-induced MMP-9 and basal levels of MMP-2 were reduced by inhibitors of Ras (damnacanthal) and ERK 1/2 (PD98059) in concentration-dependent manners, but not by the inhibitors of PKC (Go6983 and GF109203X) and PI3K (wortmannin; Fig. 3A
). These results suggest that Ras and ERK 1/2 signaling play a critical role in HA-induced MMP-9 secretion. To confirm this observation, we next examined ERK 1/2 activation by HA in U87MG control cells and in wt-PTEN-transfected cells. ERK 1/2 activation was observed within 5 min after HA treatment, and there was a marked increase in 15 min in control cells. In contrast, ERK 1/2 activation was significantly reduced in wt-PTEN-transfected cells compared with control cells (Fig. 3B)
.
|
Protein Phosphatase Activity of PTEN Is Critical for the Invasion of U87MG Cells Induced by HA.
To examine the role of phosphatase activity in HA-induced MMP-9 secretion, we introduced three kinds of Ad-PTEN to U87MG: wt-, protein-and-lipid-phosphatase-deficient (C124S)-, and lipid-phosphatase-alone-deficient (G129E)-PTEN. Introduction of Ad-wt-PTEN and Ad-G129E-PTEN showed suppression of HA-induced MMP-9 secretion. In contrast, Ad-C124S-PTEN infection had no effect on the secretion of MMP-9 induced by HA. This indicates that protein phosphatase activity is crucial in HA-induced MMP-9 secretion (Fig. 4A)
.
|
52 and 45%, respectively. However, Ad-C124S-PTEN-infected cells had no effect (Fig. 4B)
PTEN Also Inhibits the MMP-9 Secretion and Invasion of Other Functional-PTEN-deficient Glioma Cells, U251MG and U373MG.
To investigate whether the effect of PTEN on the reduction of MMP-9 secretion and in vitro invasion by HA was a general phenomenon of functional-PTEN-lacking glioma cells, we infected Ad-wt-PTEN, Ad-C124S-PTEN, and Ad-G129E-PTEN into U251MG and U373MG cells, stimulated with HA, and performed gelatin zymography, Western blotting, and in vitro invasion assays. Expression of PTENs in these cells were confirmed by Western blot analysis (Fig. 5A)
. Gelatin zymography showed that MMP-9 secretion was increased in Ad-LacZ and Ad-C124S-PTEN-infected U251MG and U37MG cells upon treatment of HA, whereas Ad-wt- and Ad-G129E-PTEN-infected cells suppressed the MMP-9 secretion (Fig. 5B)
. Also, FAK and ERK 1/2 activation, and in vitro invasion by HA were reduced in the Ad wt- and Ad-G129E-PTEN-infected cells compared with the cells infected by Ad-LacZ and Ad-C124-PTEN (Fig. 5, B and C)
. These data indicate that PTEN generally inhibits the MMP-9 secretion and the in vitro invasion of functional-PTEN-deficient glioma cells induced by HA.
|
| DISCUSSION |
|---|
|
|
|---|
HA, a major extracellular matrix component of brain parenchyma, facilitates glioma migration and invasion through receptors such as CD44 (7 , 9 , 18) . However, the mechanisms of migration and invasion of glioma cells induced by HA are not well understood. To study the mechanisms of stimulation of MMP-9 secretion and invasion of the cells by HA, we used damnacanthal and PD98059, specific inhibitors of Ras and MAPK kinase-1, respectively, and an antisense oligonucleotide of FAK. We found that the inhibitors and antisense oligonucleotide reversed HA-induced secretion of MMP-9 in U87MG cells. However, Go6983 and GF109203X, and wortmannin, specific inhibitors of PKC and PI3K, respectively, did not influence the secretion of MMP-9. These results suggest the possibility that HA-induced MMP-9 secretion and in vitro invasion of glioma cells might be achieved by the FAK-ERK 1/2 and/or the Ras-ERK 1/2 pathways, but not by the PKC or PI3K pathways, although the specific mechanism needs to be further elucidated.
One of the main substrates of the PTEN protein is FAK (13) . FAK is required for the integrin-mediated Ras-ERK 1/2 signaling pathway (19) and modulates cellular adhesion, migration, invasion, and cytoskeletal formation (13 , 15) . Gliomas are typically highly invasive and express high levels of FAK; the inhibition of FAK reduces invasion (20) . FAK is also involved in the activation of MMPs secretion induced by fibronectin or ConA (21 , 22) . In our study, HA induced MMP-9 secretion in U87MG cells and activated the phosphorylation of FAK. Antisense oligonucleotides to FAK reduced MMP-9 secretion and invasion in these cells. Therefore, our results suggest that FAK may be involved, at least in part, in the HA-induced MMP-9 secretion and invasion of the cells through the ERK 1/2 pathway.
Although inhibition of FAK reduces the invasion of glioma cells, PTEN status does not influence the phosphorylation of FAK (20) . In addition, functional-PTEN expression in U87MG cells does not inhibit FAK phosphorylation induced by fibronectin, and the phosphatase domain of the PTEN protein is not required in the invasion of glioma cells (17) . On the contrary, Tamura et al. (13 , 15) showed that the suppression of FAK-mediated cell spreading, migration, invasion, and cytoskeletal formation in glioma cells with mutated PTEN alleles, by expression of exogenous PTEN, requires protein phosphatase activity. Furthermore, Koul et al. (16) recently showed that expression of wt-PTEN in U251MG glioma cells results in the inhibition of MMP-2 expression and invasion, and that the phosphatase activity of PTEN is essential for this function. In our study, HA-induced phosphorylation of FAK and ERK 1/2, secretion of MMP-9, and invasion were reduced by the stable transfection of functional PTEN in U87MG cells. Furthermore, infection of Ad-wt- and Ad-G129E-PTEN, but not of Ad-C124S-PTEN, reduced the phosphorylation of FAK, MMP-9 secretion, and invasion of U87MG cells. In addition, the infection of Ad-wt-PTEN and Ad-G129E-PTEN in U251MG and U373MG, other functional-PTEN-deficient cells, also reduced phosphorylation of FAK and ERK 1/2, secretion of MMP-9, and invasion by HA. Therefore, our results suggest that the protein phosphatase activity of PTEN is required in the inhibition of HA-induced activation of FAK and the invasion of these glioma cells.
In summary, we suggest that HA induces the invasion of glioma cells by the induction of MMP-9 through the FAK-ERK 1/2 signaling pathway. Introduction of the functional-PTEN gene decreases these effects and the protein phosphatase activity of the PTEN protein is critical in these events.
| FOOTNOTES |
|---|
1 Supported by the National Cancer Control Program of the Ministry of Health and Welfare and the National Nuclear R & D program of the Ministry of Science and Technology, Seoul, Korea. ![]()
2 To whom requests for reprints should be addressed, at Neurooncology Clinic, National Cancer Center, 809 Madu-dong, Ilsan-gu, Goyang, Gyeonggi, 411-351, Korea. Phone: 82-31-920-1660; Fax: 82-31-920-1520; E-mail: nslsh{at}ncc.re.kr ![]()
3 The abbreviations used are: MMP, matrix metalloproteinase; HA, hyaluronic acid; FAK, focal adhesion kinase; PI3K, phosphoinositide 3-kinase; PKC, protein kinase C; MAPK, mitogen-activated protein kinase; ERK 1/2, extracellular signal-regulated kinase 1/2; TIMP, tissue inhibitor of metalloproteinase; wt, wild type; Ad, adenoviral; HEK, human embryonic kidney. ![]()
Received 3/ 5/02. Accepted 8/26/02.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Selvendiran, M. L. Kuppusamy, A. Bratasz, L. Tong, B. K. Rivera, C. Rink, C. K. Sen, T. Kalai, K. Hideg, and P. Kuppusamy Inhibition of Vascular Smooth-Muscle Cell Proliferation and Arterial Restenosis by HO-3867, a Novel Synthetic Curcuminoid, through Up-Regulation of PTEN Expression J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 959 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roy, S. Khanna, S.-R. A. Hussain, S. Biswas, A. Azad, C. Rink, S. Gnyawali, S. Shilo, G. J. Nuovo, and C. K. Sen MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue Cardiovasc Res, April 1, 2009; 82(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, Y.-S. Lee, J. Choe, H. Lee, Y.-M. Kim, and D. Jeoung CD44-Epidermal Growth Factor Receptor Interaction Mediates Hyaluronic Acid-promoted Cell Motility by Activating Protein Kinase C Signaling Involving Akt, Rac1, Phox, Reactive Oxygen Species, Focal Adhesion Kinase, and MMP-2 J. Biol. Chem., August 15, 2008; 283(33): 22513 - 22528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, S. Wang, B. Sung, G. Lim, and J. Mao Morphine Induces Ubiquitin-Proteasome Activity and Glutamate Transporter Degradation J. Biol. Chem., August 1, 2008; 283(31): 21703 - 21713. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gong, L. Meng, B. Jiang, J. Zhang, H. Yang, J. Wu, and C. Shou p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR Mol. Cancer Ther., March 1, 2008; 7(3): 530 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Park, H.-J. Kwak, H.-C. Lee, D.-H. Yoo, I.-C. Park, M.-S. Kim, S.-H. Lee, C. H. Rhee, and S.-I. Hong Nerve Growth Factor Induces Endothelial Cell Invasion and Cord Formation by Promoting Matrix Metalloproteinase-2 Expression through the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway and AP-2 Transcription Factor J. Biol. Chem., October 19, 2007; 282(42): 30485 - 30496. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bedolla, T. J. Prihoda, J. I. Kreisberg, S. N. Malik, N. K. Krishnegowda, D. A. Troyer, and P. M. Ghosh Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation Clin. Cancer Res., July 1, 2007; 13(13): 3860 - 3867. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Park, M.-J. Park, H.-J. Kwak, H.-C. Lee, M.-S. Kim, S.-H. Lee, I.-C. Park, C. H. Rhee, and S.-I. Hong Ionizing Radiation Enhances Matrix Metalloproteinase-2 Secretion and Invasion of Glioma Cells through Src/Epidermal Growth Factor Receptor-Mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways. Cancer Res., September 1, 2006; 66(17): 8511 - 8519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Nelson, S. Subbaram, K. M. Connor, J. Dasgupta, X.-F. Ha, T.-C. Meng, N. K. Tonks, and J. A. Melendez Redox-dependent Matrix Metalloproteinase-1 Expression Is Regulated by JNK through Ets and AP-1 Promoter Motifs J. Biol. Chem., May 19, 2006; 281(20): 14100 - 14110. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Bae, M.-J. Park, S. H. Yoon, S. W. Kang, S.-S. Lee, K.-M. Choi, and H.-D. Um Bcl-w Promotes Gastric Cancer Cell Invasion by Inducing Matrix Metalloproteinase-2 Expression via Phosphoinositide 3-Kinase, Akt, and Sp1. Cancer Res., May 15, 2006; 66(10): 4991 - 4995. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valiente, A. Andres-Pons, B. Gomar, J. Torres, A. Gil, C. Tapparel, S. E. Antonarakis, and R. Pulido Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases J. Biol. Chem., August 12, 2005; 280(32): 28936 - 28943. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Xiao, C. Yin, C. Yang, A. Di Cristofano, P. P. Pandolfi, and T. Van Dyke Somatic Induction of Pten Loss in a Preclinical Astrocytoma Model Reveals Major Roles in Disease Progression and Avenues for Target Discovery and Validation Cancer Res., June 15, 2005; 65(12): 5172 - 5180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Lakka, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, V. H. Rao, C. Sioka, and J. S. Rao Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas J. Biol. Chem., June 10, 2005; 280(23): 21882 - 21892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Kim, M.-J. Park, E.-J. Moon, S.-J. Kim, C.-H. Lee, H. Yoo, S.-H. Shin, E.-S. Song, and S.-H. Lee Hyaluronic Acid Induces Osteopontin via the Phosphatidylinositol 3-Kinase/Akt Pathway to Enhance the Motility of Human Glioma Cells Cancer Res., February 1, 2005; 65(3): 686 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baronas-Lowell, J. L. Lauer-Fields, J. A. Borgia, G. F. Sferrazza, M. Al-Ghoul, D. Minond, and G. B. Fields Differential Modulation of Human Melanoma Cell Metalloproteinase Expression by {alpha}2{beta}1 Integrin and CD44 Triple-helical Ligands Derived from Type IV Collagen J. Biol. Chem., October 15, 2004; 279(42): 43503 - 43513. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Kim, M. A. Wheeler, C. M. Wilson, J. Iida, D. Eng, M. A. Simpson, J. B. McCarthy, and K. M. Bullard Hyaluronan Facilitates Invasion of Colon Carcinoma Cells in Vitro via Interaction with CD44 Cancer Res., July 1, 2004; 64(13): 4569 - 4576. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyata, T. Sato, M. Yano, and A. Ito Activation of protein kinase C {beta}II/{varepsilon}-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin Mol. Cancer Ther., July 1, 2004; 3(7): 839 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Song, G. N. Fuller, A. Khan, S. Kong, W. Shen, E. Taylor, L. Ramdas, F. F. Lang, and W. Zhang IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion PNAS, November 25, 2003; 100(24): 13970 - 13975. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zoltan-Jones, L. Huang, S. Ghatak, and B. P. Toole Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells J. Biol. Chem., November 14, 2003; 278(46): 45801 - 45810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ward, L. Huang, H. Guo, S. Ghatak, and B. P. Toole Perturbation of Hyaluronan Interactions Inhibits Malignant Properties of Glioma Cells Am. J. Pathol., May 1, 2003; 162(5): 1403 - 1409. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |